国产av不卡一区二区_欧美xxxx做受欧美_成年人看的毛片_亚洲第一天堂在线观看_亚洲午夜精品久久久中文影院av_8x8ⅹ国产精品一区二区二区_久久精品国产sm调教网站演员_亚洲av综合色区无码一二三区_成人免费激情视频_国产九九九视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / China-Europe

'Right steps' point to a healthier China

By Wang Mingjie | China Daily Europe | Updated: 2017-12-10 20:53
Share
Share - WeChat

Country will benefit greatly from medical research and policy changes, says executive of pharmaceutical giant

Dieter Weinand, president of the pharmaceuticals division and a member of the management board of Bayer AG, speaks at Annual Pharmaceuticals Media Day in Berlin on Dec 1. Provided to China Daily

China's emphasis on innovation in recent years has led to more opportunities for global clinical development and research programs to be conducted in the country, something that has benefited its people, says a leading executive at a top German pharmaceutical company.

Dieter Weinand, president of Bayer AG's pharmaceuticals division and a member of the company's management board, said: "The Chinese government is taking the right steps in assuring that new medicines can be approved in China faster, by allowing full studies conducted in other countries to be utilized and updated in China."

He said the company used to have to set up separate programs for China, which meant it took much longer for new drugs to reach Chinese customers.

Speaking at the Annual Pharmaceuticals Media Day in Berlin, Weinand said: "The ability to include Chinese patients now in clinical research and development in a global program will automatically bring more clinical research into China."

He said the company welcomes the Chinese government's recent reforms, which "make it much easier for us to get drugs to the market faster in China". Weinand said the move also adds an incentive for Bayer to conduct more comprehensive and advanced clinical research at its China Innovation Center in Beijing, which until now has only hosted early-stage research.

Bayer's links with China go back a long way: The business established a presence in the country in 1882. As a leading global company in the fields of healthcare and agriculture, its classic medicine - aspirin - has a history going back 120 years.

Today, China is Bayer's largest single market in Asia, accounting for sales of more than 2.67 billion euros ($3.18 billion; £2.36 billion) in 2016. Its Chinese workforce numbers more than 10,000.

Weinand said the company's vision in relation to China is in line with the government's policy of improving the lives of Chinese people. He believes "a healthier population is more productive and a more productive population results in better economic status, and therefore a better life.

"We have a program in place with the Chinese government to support the Go West initiative, where we provide unrestricted grants and efforts for the Chinese government to bring better healthcare to the more western provinces in China. Our support has resulted in the training of physicians, not only in medical capabilities but also in administration of healthcare system and hospitals."

Thousands of physicians are being trained. The company recently signed a new agreement for the next five years, in which it commits to continue to support the effort to change the imbalance in medical care between the rural west and urban east.

Weinand said this aim aligns with the Chinese government's mission to tackle the current principal contradiction faced by the Chinese people, which is the tension between "unbalanced and inadequate development and the people's ever-growing needs for a better life". It was outlined in October by President Xi Jinping at the 19th National Congress of the Communist Party of China.

Weinand said China is on the brink of an innovation revolution in medicine, not only in treatment and clinical medicine but also in terms of the number of scientists at work.

"I recently went into an organ transplant center in Shanghai and was shocked at the success rate they have, as well as the capabilities. Even the world's leading experts are going to visit this transplant center in China to learn," he said.

Weinand applauded the consolidation that has happened, and continues to happen, in China among thousands of small, generic companies that used to co-exist and carry out their own small-scale research. He said these were not cost-efficient and their research was not always of high quality before consolidation.

"When you have a handful of major generic companies that propose high-quality generics for the Chinese market, there will no longer be any difference between the original and the generic. That allows you to treat patients inexpensively, so money can be reinvested into innovative pharmaceuticals, leading to high-quality generics at a low price for everybody, rather than paying a higher price for the originator of the patent. That innovation drive is going to be good for Chinese patients," he said.

Moving forward, Weinand said he would welcome continued progress in matters including regulatory reform, innovation, value pricing and national drug listing.

"I would like to see more frequent additions (of medicine) to the national reimbursement list. There were years when nothing was added. That is not helpful to Chinese patients, nor to innovation," he said, adding value-based evaluations of medical products should be introduced.

Last year, Bayer increased its global investment in research and development by 9.2 percent, to nearly 4.7 billion euros. Around 60 percent of that total (nearly 2.8 billion euros) was assigned to the development of new pharmaceuticals, with a focus on therapeutic areas of cardiology, oncology and women's healthcare.

In 2017, the company plans to further increase its overall research and development spending to about 4.8 billion euros.

As an innovative player in women's healthcare, Bayer has been pioneering the promotion of the estrogen balance management concept among Chinese women. Under the Post Abortion Care Project, the company is also making long-term efforts to educate women about effective contraception and reduce the harm caused by repeated abortions. To date, the project has benefited more than 6 million women.

Noting that China is Bayer's second-largest market globally, Weinand said the company is determined to further expand its involvement in the country, to improve the its healthcare and medical services and help in offering better lives to Chinese patients.

wangmingjie@mail.chinadailyuk.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
欧美日韩国产高清一区| 欧美日韩xx| 色婷婷亚洲十月十月色天| 国内精品久久久久久影院8f| 国内揄拍国内精品| 久久精品国产一区二区电影| 精品一区精品二区| 日韩精品一区二区在线观看| 亚洲在线视频网站| 国产精品视频一二三区| 国产一区二区看久久| 日韩中文欧美在线| 亚洲精品裸体| 中文精品久久| 91一区在线| 欧美禁忌电影网| 精品深夜福利视频| 福利视频一区| 欧美××××黑人××性爽 | 欧美日韩免费在线观看| 亚洲欧美电影一区二区| 国产精品黄色在线观看| 久久久久国产免费免费| 99riav一区二区三区| 国产ts人妖一区二区| 蜜桃av一区二区| 久久中文在线| 久久精选视频| 亚洲三级国产| 亚洲激情午夜| 亚洲高清不卡| 亚洲黄色毛片| 欧美国产91| 欧美午夜在线视频| 成人高清av| 欧美呦呦网站| 久久精品国产亚洲夜色av网站| 精品高清在线| 成人综合专区| 日韩成人三级| 婷婷亚洲五月色综合| 欧美aaaa视频| 亚洲国产精品久久久久蝴蝶传媒| 91影院成人| 亚洲精品国产成人影院| 一区二区蜜桃| 亚洲视频精品| 国产伦理一区| 日韩国产精品久久久| 天堂在线一区二区| 日本不卡一区二区三区高清视频| 日韩高清电影一区| 男男视频亚洲欧美| 久久99国内精品| 国产在线精品不卡| 极品销魂美女一区二区三区| 免费在线观看精品| 激情图区综合网| 国产成人在线视频网址| 成人国产精品免费观看动漫| 成人免费视频国产在线观看| 99re这里只有精品视频首页| 粉嫩av一区二区三区粉嫩| 成人免费视频caoporn| 99re视频这里只有精品| 国产日韩高清在线| 亚洲同性gay激情无套| 亚洲国产婷婷综合在线精品| 欧美性jizz18性欧美| 欧美日韩一二三四五区| 欧美性受xxxx黑人xyx性爽| 欧美视频专区一二在线观看| 欧美日韩中文另类| 欧美电影免费提供在线观看| 亚洲欧美激情一区| 久久久国产一区二区| 午夜精品一区二区三区在线 | 中文字幕在线观看一区二区| 亚洲欧美日本在线| 欧美日韩国产综合视频在线观看中文| 在线日韩一区二区| 欧美一区二区三区免费视频| 日韩成人在线播放| 久久久久www| 免费视频拗女稀缺一区二区 | www在线免费观看| 女人天堂av在线播放| 欧美特大特白屁股xxxx| 亚洲资源在线| 私拍精品福利视频在线一区| 欧美gay男男猛男无套| 亚洲一区二区三区无吗| 国产欧美在线| 国产精一品亚洲二区在线视频| 久久夜色精品国产噜噜av| 亚洲欧美日韩综合aⅴ视频| 亚洲综合在线第一页| 欧美日韩视频在线观看一区二区三区| 精品国产伦一区二区三区观看方式 | 日韩在线视频免费观看| 一区二区三区激情| www操com| 福利在线播放| 天堂久久午夜av| 国产99久久精品一区二区300| 国产精品腿扒开做爽爽爽挤奶网站| 福利91精品一区二区三区| 亚洲免费三区一区二区| 在线播放中文一区| 久久精品久久久久久国产 免费| 日本欧美色图| 特黄aaaaaaaaa毛片免费视频| 国产高清一区二区三区视频| 国产精品麻豆| 欧美日韩亚洲一区二区三区在线| 国内久久精品视频| 亚洲女同一区二区| 日韩午夜在线影院| 欧美大片免费看| 免费免费啪视频在线观播放| 久草福利在线| 国产精品久久久久久妇女| 日韩精品网站| 国产一区二区福利视频| 亚洲一区在线电影| 日韩电影免费观看在线观看| 68精品国产免费久久久久久婷婷| 成人黄网18免费观看的网站| 久操免费在线| japanese色系久久精品| 国产精品久久久久9999高清| 国产免费观看久久| 欧美丰满一区二区免费视频 | 亚洲国产精品国自产拍av| 精品视频在线视频| 欧美猛男性生活免费| 免费91视频| 阿v免费在线观看| 久久久国产精品入口麻豆| 韩日精品视频| 国产亚洲欧美在线| 在线不卡a资源高清| 久久久噜久噜久久综合| 天天色天天看| 午夜小视频在线观看| 亚洲va久久| 麻豆精品国产91久久久久久| 一区二区三区在线视频免费观看| 亚洲精品720p| 国产剧情av片巨作醉酒女邻居 | 久久av.com| 5858p先锋影音资源网| 亚洲综合图区| 九九精品在线| 成人在线一区二区三区| 色婷婷综合久色| 欧美巨大黑人极品精男| 成人免费乱码大片a毛片软件| 蜜桃av在线免费观看| 日本韩国欧美超级黄在线观看| 蜜臀av在线播放一区二区三区| 亚洲午夜久久久久久久久久久| 亚洲男人av在线| 小小的日本在线观看免费色网| 99视频在线观看地址| av自拍一区| 美女视频黄 久久| 欧美性色19p| 色综合视频一区中文字幕| 黄色一级影院| 国产成人77亚洲精品www| 日韩视频在线一区二区三区| ...中文天堂在线一区| 亚洲人成在线电影| 成年免费插网| 激情aⅴ欧美一区二区欲海潮| 亚洲五月综合| 国产精品久久免费看| 亚洲美女激情视频| 免费操人视频| 欧美日韩国产观看视频| 午夜国产精品视频免费体验区| 欧美国产视频在线| 亚洲黄色有码视频| 青青操夜夜操| av中文字幕在线观看第一页| 中文在线日韩| 最近中文字幕一区二区三区| 国产亚洲xxx| 天天干夜夜操| 免费污视频在线一区| 另类国产ts人妖高潮视频| 午夜精品久久久久久久| 欧美激情啊啊啊| 在线一级视频| 国产精品香蕉| 99在线精品一区二区三区| 日韩欧美www| 羞羞视频网站| 欧美黄色网页| 日韩电影一二三区| 欧美无人高清视频在线观看| 四虎成人精品在永久免费| 日日夜夜精品一区| 四虎成人av| 综合分类小说区另类春色亚洲小说欧美| 国产亚洲欧美视频| 黄色免费观看网站| 涩爱av色老久久精品偷偷鲁| 国产麻豆成人精品| 欧美一级一区二区| 日日日日人人人夜夜夜2017| 波多视频一区| 日韩福利电影在线观看| 欧美日韩在线综合| 国产精品久久久久久久久鸭| 91视频欧美| 米奇777在线欧美播放| 日本黄色一区二区| 欧美老tube| 国产无遮挡裸体视频在线观看| 亚洲美女一区| 色欧美片视频在线观看在线视频| 久久日.com| 美女尤物在线视频| 国产精品久久国产愉拍| 91久久国产最好的精华液| 久久一本精品| 女生影院久久| 黑人巨大精品欧美黑白配亚洲| 884aa四虎影成人精品一区| 樱花草在线观看www| 欧美精品国产白浆久久久久| 成人免费在线电影网| 成人美女在线观看| 亚洲国产中文字幕久久网| 天天色天天草| 波多野结衣一区二区三区免费视频| 99免费精品视频| 一区二区av在线| 在线观看中文字幕| 日韩欧美视频在线播放| 亚洲精品日韩综合观看成人91| 午夜精品在线视频| 成人免费在线| 一区二区精品| 欧美精品丝袜久久久中文字幕| 女生裸体免费视频| 97精品资源在线观看| caoporn国产一区二区| 伊人久久久久久久久久久久久| 中文字幕在线视频不卡| 精品国产一区二区三区噜噜噜| 尤物视频一区二区| 色偷偷av男人的天堂| av影院在线免费观看| 久久精品国产免费| 亚洲成年网站在线观看| 欧美福利网站| 激情五月综合网| 亚洲夂夂婷婷色拍ww47| 欧美精品另类| jizz免费一区二区三区| 99精品视频在线观看免费| 日韩综合中文字幕| 日本中文字幕在线观看| 国产日韩一区二区三区在线| 欧美一区二区三区四区五区 | 成年网站在线| 亚洲激情亚洲| 欧美一区二区视频免费观看| 成年人视频在线网站| 欧美人妖在线| 亚洲成人一区二区| 国产精品视频流白浆免费视频| 亚洲精品69| 国产欧美日产一区| 久久久久久久一| 免费毛片b在线观看| 国产精品一二三四| 日韩中文字幕网址| 二区三区在线观看| 麻豆一区二区三| 国产午夜精品一区二区三区| 999在线视频| 日韩极品在线观看| 亚洲女人被黑人巨大进入| 狠狠v欧美ⅴ日韩v亚洲v大胸| 亚洲激情婷婷| 精品国产百合女同互慰| 亚洲人成77777男人| 亚洲婷婷在线| 精品国精品国产| 一个人免费观看视频www在线播放| 欧美久久一级| 日韩精品一区二| 亚洲人av在线| 国产精品资源| 亚洲色图偷窥自拍| 午夜伦全在线观看| 美腿丝袜亚洲色图| 日韩在线视频播放| 国产黄色大片在线观看| 成人高清在线视频| 91国内在线视频| 免费在线成人激情电影| 国产精品美女www爽爽爽| 欧美另类videos粗暴黑人| 91精品国产自产在线丝袜啪| 一区二区三区av电影| 免费看成年人视频| 欧美丝袜一区| 欧美日韩一区二区三区在线| 超碰在线中文| 亚洲综合99| 在线观看国产精品淫| 亚洲欧美成人影院| 成人黄色777网| 一二三四视频在线社区中文字幕2| aa亚洲一区一区三区| 亚洲精品免费视频| 成年网址网站在线观看| 三区四区不卡| 日韩无一区二区| 国产精品四虎| 精品一区二区国语对白| 欧美乱妇高清无乱码| 你懂得影院夜精品a| 一区二区中文字幕在线| 日日干日日操| 色综合天天爱| 日韩精品资源二区在线| 都市激情一区| 国产米奇在线777精品观看| 久久久最新网址| 成人污版视频| 午夜精品影院在线观看| 1024手机看片国产| 亚洲欧洲视频| 中文字幕亚洲字幕| 成人av三级| 亚洲男人的天堂av| www.激情| 国产精品大片| 在线色欧美三级视频| 黄色aa久久| 亚洲欧洲日本在线| 岛国av在线| 悠悠资源网久久精品| 一区二区三区久久精品| 性国裸体高清亚洲| 亚洲人成影院在线观看| 成人黄网18免费观看的网站| 亚洲视频www| 久热99视频在线观看| 开心久久婷婷综合中文字幕 | 尤物视频在线观看免费| 99免费精品| 亚洲三级黄色在线观看| 亚洲女同av| 亚洲综合久久av| 95影院理论片在线观看| 日韩va欧美va亚洲va久久| 午夜精品久久久久久久久久久久久 | 一区二区网站| 欧美日韩一级视频| porn亚洲| 久久美女艺术照精彩视频福利播放| 国产精品在线| 欧美女人交a| 日韩网站免费观看高清| 亚洲伊人精品酒店| 在线视频你懂得一区二区三区| 国产精品视频二区三区| 99国产精品久久久久久久久久久| 国产成人精品18| 国产综合激情| 久久九九亚洲综合| 亚洲精品a区| 91精品久久久久久久久99蜜臂| 免费在线观看黄色| 欧美精彩视频一区二区三区| 北条麻妃av毛片免费观看| 欧美一级播放| 亚洲成人黄色小说| 国产一区二区三区四区| 国产婷婷色综合av蜜臀av| 三上悠亚国产精品一区二区三区| 午夜精品久久久久久久久久久| 色猫av在线| 91一区二区在线观看| 蜜桃狠狠狠狠狠狠狠狠狠| 亚洲一区二区网站| 国内精品免费午夜毛片| 偷拍亚洲精品| 亚洲精品一区av在线播放| 精品裸体bbb| 欧美日韩一级二级| 丰满大乳少妇在线观看网站| 亚洲一区二区综合|